Fludarabine + Cyclophosphamide + TAA05 Cell Injection Clinical Trials

1 actively recruiting trial

Also known as: Fludarabine + Cyclophosphamide + Anti-FLT3 CAR-T Cell

Pipeline

Phase 1: 1

Top Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology1

Indications

Acute Myeloid Leukemia1
Cancer1

Other1 trial

Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid Leukemia

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.